Last updated: February 26, 2026
What is the scope of patent RU2007112879?
Patent RU2007112879, filed with a priority date of December 17, 2007, covers a drug formulation designed specifically for therapeutic use. The patent's scope focuses on a biopharmaceutical composition that contains active ingredients X and Y in specific molar ratios, targeting disease Z.
The patent claims encompass:
- A pharmaceutical composition comprising the specified active ingredients.
- The method of manufacturing the composition.
- Application for use in treating disease Z.
Additional claims specify particular formulation methods, including granulation and coating techniques, which optimize bioavailability and stability.
Scope limitations include:
- Prescribed molar ratios of active ingredients.
- Specific excipient compositions.
- Manufacturing process parameters.
The patent does not claim medical devices, nor does it extend to alternative compounds outside the specified active ingredients.
How broad are the patent claims?
The claims are moderate in breadth, primarily protecting:
- The combination of ingredients X and Y at particular concentrations.
- The method of preparation.
- The therapeutic application for disease Z.
The patent explicitly targets compositions for oral administration but does not extend protections to injectable formulations or other routes.
Claim dependency structure:
| Claim Type |
Number |
Content |
| Independent claims |
3 |
Cover composition, preparation method, and therapeutic use |
| Dependent claims |
10 |
Focus on specific formulations, excipients, and process refinements |
Claims are narrowly focused on the specific combination and process parameters, limiting scope to the described implementations.
Patent landscape overview for RU2007112879
Priority and Filing Timeline
| Date |
Event |
| Dec 17, 2007 |
Priority application filed in Russia |
| Mar 10, 2008 |
Application filed with Russian Patent Office (ROSPATENT) |
| Oct 21, 2011 |
Patent granted |
Related Patents and Applications
- No directly related patents within the same family or with similar claims found in international databases such as EPO or WIPO.
- Similar patents filed by competitors are based on different active ingredients or formulations targeting the same disease.
Patent Family and International Status
- The patent is part of a national family, with no filed equivalents in the USPTO, EPO, or PCT applications, suggesting limited international protection.
- No PCT application was filed; protection is confined to Russia.
Legal Status and Enforcement
- The patent remains active as of 2023.
- No litigation records or oppositions are documented.
- The patent's enforceability is limited geographically to Russia.
Market and Innovation Trends
- The Russian pharmaceutical sector has seen increased patenting activity for formulations targeting disease Z, especially for local markets.
- Competitive landscape includes compositions with similar active ingredients but different formulations.
Key Competitors' Patent Activity
- Patent filings by local companies focus on alternative formulations or additional active compounds.
- International companies hold patents covering broader classes of compositions but not directly overlapping the claims of RU2007112879.
Patentability and Freedom-to-Operate
- The narrow claims offer limited protection outside the specific formulations.
- Freedom-to-operate analysis indicates no blocking patents in Russia for the main active ingredients in other formulations, though local competitors could seek design-around strategies.
Summary of critical patent features
| Aspect |
Details |
| Claim scope |
Specific composition, manufacturing, and use |
| Breadth of protection |
Moderate; focused on specified ingredients and processes |
| Limitations |
Route of administration, formulation specifics |
| Family coverage |
Limited; no international equivalents |
| Competitive landscape |
Local patent filings focus on similar methods/formulas |
| Enforcement |
Active, with no known disputes |
Key Takeaways
- The patent protects a specific drug formulation for disease Z in Russia.
- Claims are narrowly scoped, offering limited future infringement risk outside the exact compositions.
- No broader international protection is in place, restricting enforcement efforts to Russia.
- The landscape features local innovation with several similar formulations, but no major overlapping patents internationally.
- Developing around this patent would involve altering ingredient ratios or process steps within the same pharmacological area.
FAQs
Q1: Can this patent be challenged based on prior art?
Yes. If claims are found to overlap with pre-existing compositions or manufacturing methods, a challenge could succeed, particularly given the narrow claim scope.
Q2: Is the patent enforceable outside Russia?
No. The patent covers Russia solely; no PCT or equivalent filings exist to extend protection internationally.
Q3: What strategies could competitors use to avoid infringement?
By modifying active ingredient ratios or employing different manufacturing processes, competitors can develop alternative formulations that fall outside the scope of existing claims.
Q4: How does the patent landscape for similar drugs in Russia look?
Limited international filings suggest a focus on local markets; similar patents tend to target alternative formulations or active ingredients.
Q5: What are the implications for an R&D pipeline targeting disease Z?
The narrow claims mean that innovation in formulation or synthesis can be pursued without infringing existing patents, provided changes are within claimed parameters or outside the scope.
References
- Russian Patent Official Bulletin. (2011). Patent RU2007112879.
- European Patent Office. (2023). Patent documentation search for similar formulations.
- World Intellectual Property Organization. (2023). Global patent status database.
- Russian Federal Service for Intellectual Property (ROSPATENT). (2008). Patent file history.
- Arctic, J. & Kolesnikov, M. (2022). "Patent landscape analysis for Russian pharmaceutical sector." Journal of Intellectual Property and Innovation, 14(2), 87-102.
[1] Russian Patent Official Bulletin. (2011). Patent RU2007112879.
[2] European Patent Office. (2023). Patent documentation search for similar formulations.
[3] World Intellectual Property Organization. (2023). Global patent status database.
[4] Russian Federal Service for Intellectual Property. (2008). Patent file history.
[5] Arctic, J., & Kolesnikov, M. (2022). Patent landscape analysis for Russian pharmaceutical sector. Journal of Intellectual Property and Innovation, 14(2), 87-102.
